| Dr William Frederick Gowski, MD | |
|
5848 Fashion Blvd, Murray, UT 84107-6121 | |
| (801) 314-4808 | |
| (801) 314-4919 |
| Full Name | Dr William Frederick Gowski |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 22 Years |
| Location | 5848 Fashion Blvd, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275714115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 5416093-8905 (Utah) | Secondary |
| 2086S0105X | Surgery - Surgery Of The Hand | 5416093-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Orthopedic Specialty Hospital | Murray, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Orthopedic Clinic Lc | 8527090729 | 27 |
News Archive
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives.
Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives.
Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.
› Verified 1 days ago
| Entity Name | The Orthopedic Clinic Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033148986 PECOS PAC ID: 8527090729 Enrollment ID: O20050908000871 |
News Archive
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives.
Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives.
Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Frederick Gowski, MD 5848 Fashion Blvd, Suite 120, Murray, UT 84107-6121 Ph: (801) 314-4900 | Dr William Frederick Gowski, MD 5848 Fashion Blvd, Murray, UT 84107-6121 Ph: (801) 314-4808 |
News Archive
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives.
Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.
› Verified 1 days ago
Dr. Philippe Paci, MDCM Surgery Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 210, Murray, UT 84107 Phone: 507-284-2511 | |
Mark John Ott, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5169 S Cottonwood St, Suite 400, Murray, UT 84107 Phone: 801-507-3462 Fax: 801-507-3061 | |
Dr. Greg R. Goodman, MD Surgery Medicare: Medicare Enrolled Practice Location: 5323 S. Woodrow Street, #102, Murray, UT 84107 Phone: 801-713-1010 Fax: 801-713-0665 | |
Dr. Steven W Merrell, MD Surgery Medicare: Medicare Enrolled Practice Location: 5323 S. Woodrow Street, #102, Murray, UT 84107 Phone: 801-713-1010 Fax: 801-713-0665 | |
Robert Dirk Noyes, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 5169 Cottonwood St, #440, Murray, UT 84107 Phone: 801-507-3915 Fax: 801-507-3916 | |
Clark J Rasmussen, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5169 Cottonwood St, Suite 410, Murray, UT 84107 Phone: 801-266-8850 | |
Steven R Granger, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5169 S Cottonwood St Ste 400, Murray, UT 84107 Phone: 801-507-3460 Fax: 801-507-3458 |